Ozone therapy uses ozone gas (O3) to trigger therapeutic responses in the body, primarily through controlled oxidative stress that activates the body’s own antioxidant defenses and modulates inflammation. Clinicians have used it for more than a century across Europe and the Americas. The strongest human evidence supports intradiscal ozone for herniated-disc pain and ozone injection for knee osteoarthritis. Most other uses rest on small trials, case series, or laboratory data.
Key Takeaways
- The strongest ozone evidence is for pain: a 2024 meta-analysis by Chang and colleagues found intradiscal ozone outperformed steroid injection for herniated-disc pain (odds ratio 3.95 at six months or longer), and a 2020 review by Sconza covering 11 RCTs (858 patients) supports ozone injection for knee osteoarthritis.
- Ozone therapy is not FDA-approved. Under 21 CFR 801.415 the FDA classifies ozone as a toxic gas with no proven medical use at safe concentrations, so ozone generators cannot be marketed as medical devices in the United States.
- In the only head-to-head human trial (Pasek, 2023, n=114), topical HBOT reduced venous-ulcer area 69.7 percent versus ozone’s 41.3 percent, though ozone gave more pain relief.
- Systemic ozone has a strong safety record when done correctly: Viebahn-Hansler and colleagues (2016) reviewed roughly 11,000 major-autohemotherapy treatments and over 47,000 rectal insufflations with only two documented adverse events.
- Costs run from about $75 per session for rectal insufflation to $1,500 for 10-Pass or EBOO, with a typical major-autohemotherapy course of $2,000 to $6,000. Insurance almost never covers it.
This guide covers every major form of ozone therapy, what the human evidence actually shows condition by condition, realistic 2026 costs, safety and contraindications, and how to find a qualified provider.
What Is Ozone Therapy and How Does It Work?
Ozone therapy introduces medical-grade ozone (O3), a three-atom form of oxygen, into blood or tissue to create a brief, controlled oxidative stress. That stress signals the body to raise its own antioxidant and anti-inflammatory defenses. The gas is never inhaled. It is delivered through blood, injection, insufflation, or topical oils.
Ozone (O3) is unstable and highly reactive, and that reactivity is the point of the therapy. When medical-grade ozone contacts blood or tissue, it breaks down within seconds into reactive oxygen species and lipid oxidation products. These act as signaling molecules that activate the transcription factor Nrf2, which switches on antioxidant enzymes such as superoxide dismutase, glutathione peroxidase, and catalase. Sagai and Bocci (2011) described this two-sided mechanism directly: moderate oxidative stress activates the protective Nrf2 pathway, while excessive stress activates NF-kB and drives inflammation and injury. The line between benefit and harm is dose.
Leon and colleagues first demonstrated this “oxidative preconditioning” in 1998, showing that repeated low, non-toxic ozone doses trained rat cells to withstand later free-radical damage. Bocci, Zanardi, and Travagli (2011) confirmed that ozone acting on human blood follows a hormetic dose-response curve, meaning a small dose helps and a large dose harms. Smith and colleagues (2017) summarized the downstream effects: improved oxygen delivery through raised 2,3-DPG in red blood cells, immune modulation through cytokine regulation, and direct antimicrobial oxidation of bacterial and viral membranes. A 2025 narrative review by Napiorkowska-Baran and colleagues catalogued ozone’s effects on macrophages, regulatory T cells, and NK-cell activity. For a fuller mechanism walkthrough, see how ozone therapy works.
What Are the Types of Ozone Therapy?
Ozone therapy is a category, not a single treatment. The main routes are blood-based (major autohemotherapy, 10-Pass, EBOO), insufflation (rectal, vaginal, ear), injection (prolozone, intradiscal), and topical (ozonated oil and water). Systemic blood and rectal methods target whole-body immune and inflammatory effects; injections and oils target a specific site.
| Modality | How It Works | Typical Use | Session Time |
|---|---|---|---|
| MAH (Major Autohemotherapy) | 100-200 mL of blood drawn, mixed with ozone, reinfused | Systemic immune support, infections, chronic illness | 30-60 min |
| 10-Pass / Multi-Pass | MAH repeated up to 10 times in one session with a pressurized ozone device | Higher-dose systemic treatment, chronic infections | 60-90 min |
| EBOO | Blood circulated through an external filter with ozone, similar to dialysis | Systemic treatment, chronic fatigue, autoimmune conditions | 45-90 min |
| Rectal Insufflation | Ozone gas introduced into the colon via catheter | Systemic absorption, gut health, immune support | 5-15 min |
| Vaginal / Ear Insufflation | Humidified ozone directed into the vaginal canal or ear canal | Local infections, sinus and ear complaints | 5-20 min |
| Prolozone / Intradiscal Injection | Ozone-oxygen injected into joints, trigger points, or a herniated disc | Joint pain, osteoarthritis, disc-related back pain | 15-30 min |
| Ozonated Oil / Water | Ozone infused into olive or sunflower oil, or bubbled through water | Wound care, skin and oral infections, burns | Topical / oral |
Major autohemotherapy is the most studied systemic form. Rectal insufflation is the most accessible, since patients can do it at home with proper equipment and training, and it reaches high systemic bioavailability. For a deeper look at the two systemic mainstays, see our guides to major autohemotherapy and rectal ozone therapy, and the higher-dose EBOO method.
What to Expect During a Major Autohemotherapy Session
A standard MAH session takes 30 to 60 minutes. The practitioner draws 100 to 200 mL of blood into a glass container, mixes it with medical-grade ozone at a set concentration (usually 20 to 60 mcg/mL), and reinfuses it through the same line. The ozonated blood turns from dark red to bright cherry red as oxygen binds. Most patients feel nothing beyond mild warmth. A typical course runs 10 to 20 sessions, one to two per week, with reassessment after the first 5 or 6.
What Conditions Is Ozone Therapy Used For?
Practitioners use ozone for a wide range of conditions, but the evidence quality varies from moderate to nonexistent. The best-supported uses are musculoskeletal and pain conditions treated with local injection, plus adjunct wound care. Systemic claims for cancer, HIV, and chronic infections are not supported by controlled human trials.
Conditions With the Strongest Evidence
- Herniated-disc and low-back pain: A 2024 meta-analysis by Chang and colleagues found intradiscal ozone superior to steroid injection (odds ratio 3.95) at six months and comparable to microdiscectomy. An earlier meta-analysis by Magalhaes (2012) reached similar conclusions with low complication rates. See ozone therapy for herniated disc.
- Knee osteoarthritis: Sconza and colleagues (2020) reviewed 11 RCTs of 858 patients and found intra-articular oxygen-ozone reduced pain and improved function comparably to other conservative injections. More at ozone therapy for joint pain.
- Chronic and diabetic wounds: Ozone as an adjunct to standard wound care improves closure rates, though it is not clearly superior on its own (covered below).
Conditions With Emerging Evidence
- Dental and periodontal disease: A 2025 systematic review by Hu and colleagues in BMC Oral Health found ozone as an adjunct to scaling and root planing improved probing depth and gingival inflammation, though the pooled effect was modest. For caries specifically, the evidence is weaker (see the FDA section). See ozone therapy for dental cavities.
- Fibromyalgia: A small double-blind RCT by Sucuoglu and Soydas (2023, n=54) and an open-label rectal-insufflation pilot by Hidalgo-Tallon (2013) reported symptom improvement, but trials remain small.
- Musculoskeletal pain broadly: A 2024 review by Jeyaraman and colleagues in the European Journal of Medical Research found anti-inflammatory and analgesic benefit across osteoarthritis, fractures, and chronic pain, while calling for larger trials.
Conditions With Limited or No Evidence
- Cancer: No controlled human trial shows ozone treats cancer. Clavo and colleagues (2018, 2019) describe a plausible adjunctive role in reducing chemotherapy and radiotherapy toxicity, but conclude randomized trials are still needed. Ozone is not a cancer cure. See ozone therapy for cancer.
- HIV/AIDS: Carpendale and Freeberg (1991) showed ozone inactivates HIV in a test tube at non-cytotoxic concentrations, but no clinical trial has shown benefit in patients.
- Chronic Lyme, chronic fatigue, most autoimmune disease: Practitioner interest is high but published evidence is limited to case reports. See ozone therapy for Lyme disease for an honest review.
What Does the Evidence Actually Say?
Ozone therapy has genuine, moderate-quality human evidence for a narrow set of pain and wound indications, and thin or laboratory-only evidence for the systemic claims it is most often marketed for. It performs best as an adjunct alongside standard care, not as a standalone cure. The table below grades each major use against the actual literature.
Ozone Therapy Evidence by Condition
| Condition | Best study type | Sample | Result | Evidence tier | Source |
|---|---|---|---|---|---|
| Herniated-disc pain | Meta-analysis of RCTs | Multiple RCTs | Superior to steroid injection (OR 3.95); comparable to microdiscectomy | Moderate-Strong | Chang, 2024 |
| Low-back pain (disc) | Systematic review + meta-analysis | 8 observational + 4 RCTs | Positive results, low morbidity | Moderate | Magalhaes, 2012 |
| Knee osteoarthritis | Systematic review of RCTs | 11 RCTs, 858 patients | Pain and function improved, comparable to other injections | Moderate | Sconza, 2020 |
| Chronic wounds | Systematic review of RCTs | 9 RCTs, 453 patients | Improved closure, but not clearly superior to standard care | Moderate | Fitzpatrick, 2018 |
| Diabetic foot ulcers | Randomized controlled trial | 61 patients | Faster healing vs standard care as adjunct | Moderate | Wainstein, 2011 |
| Venous leg ulcers | RCT (ozone vs topical HBOT) | 114 patients | Ozone reduced ulcer area 41.3%; better pain relief than HBOT | Moderate | Pasek, 2023 |
| Periodontitis | Systematic review + meta-analysis | RCTs to 2024 | Modest improvement as SRP adjunct | Emerging | Hu, 2025 |
| Dental caries | Systematic review + meta-analysis | Very low certainty | Insufficient evidence to recommend | Emerging | Santos, 2020 |
| Fibromyalgia | Double-blind RCT | 54 patients | Symptom improvement, small trial | Emerging | Sucuoglu, 2023 |
| Chemotherapy toxicity | Mechanistic review | In vitro / animal / case | Plausible adjunct, trials needed | Limited | Clavo, 2019 |
| Cancer (as treatment) | Review of preclinical + case data | No controlled trials | No proven benefit | Limited | Clavo, 2018 |
| HIV | In vitro | Laboratory only | Inactivates virus in a test tube, no clinical benefit | Limited | Carpendale, 1991 |
The single clearest signal is for pain. Chang’s 2024 meta-analysis is the closest ozone gets to definitive evidence for one indication. Wound-healing data is promising but conditional: Fitzpatrick, Holland, and Vanderlelie (2018) pooled 9 RCTs (453 patients) and found better closure with ozone, yet concluded plainly that there is no conclusive evidence it is superior to standard treatment.
“Results favor ozone but there is no conclusive evidence of ozone therapy as superior compared with standard treatments.”
Fitzpatrick, Holland & Vanderlelie, 2018, International Wound Journal
A recurring pattern is that ozone performs best as an adjunct. In wound trials, patients receiving ozone alongside standard care outperformed standard care alone. In musculoskeletal studies, ozone injections combined with physical therapy beat ozone alone. A 2025 systematic review and meta-analysis in Advances in Redox Research (12 RCTs, 846 participants) found no significant overall change in oxidative-stress markers versus controls, with benefit limited to specific groups such as type 2 diabetes, a useful reminder that the systemic story is still unsettled.
The topical ozonated-oil approach extends to skin repair. Romary and colleagues (2023) reviewed liquid ozone therapies for epithelial wounds and found improved healing and reduced pain. Early reports describe the same oil applied to burns and scars, where its antimicrobial and pro-healing action works directly on damaged tissue.
Why the gap between clinical practice and large trials? No company can patent ozone gas, so there is little commercial incentive to fund the multimillion-dollar Phase III trials that regulatory approval requires. Most ozone research comes from European universities and independent clinics rather than industry. That explains the thin trial base, but it does not turn unproven claims into proven ones. See our dedicated ozone therapy evidence review for the study-by-study detail.
Is Ozone Therapy FDA-Approved?
No. Ozone therapy is not FDA-approved for any medical use. Under 21 CFR 801.415 the FDA classifies ozone as a toxic gas with no known useful medical application at concentrations that are safe to breathe. That regulation blocks ozone generators from being marketed as medical devices, and the FDA has sent warning letters to companies that make medical claims.
This is the single most important accuracy point on the topic, and it is often stated incorrectly. Ozone therapy has zero FDA approvals. By contrast, hyperbaric oxygen therapy has 14 FDA-cleared indications, a different regulatory status that reflects a far larger trial base. Clearing a device and approving a therapy are not the same thing, and ozone has neither.
The FDA classification does not by itself make ozone therapy illegal to administer, because medical practice is regulated at the state level. Many states allow licensed physicians to use ozone under their medical license. Some, like New York, are more restrictive; others, like Texas and Florida, are more permissive. Outside the United States the picture differs sharply: Germany has practiced ozone therapy since the 1950s, and it is integrated into national care in Cuba and used in hospital settings across parts of Europe. We cover the nuances in is ozone therapy FDA-approved and why ozone therapy is sometimes called illegal.
What Are the Side Effects, Risks, and Contraindications?
Ozone therapy has a favorable safety profile when trained practitioners follow concentration protocols, but the qualifier matters. The most dangerous errors are direct intravenous injection of ozone gas, which risks air embolism, and inhalation, which damages the airways. Serious harm is rare but documented, and screening for one specific enzyme deficiency is mandatory.
Common side effects include mild fatigue or flu-like symptoms after treatment, temporary lightheadedness during blood draws, minor injection-site discomfort, and cramping after rectal insufflation.
Serious but rare risks center on route errors. Ozone must never be injected directly into a vein as a gas, and it must never be inhaled. Excessive doses can overwhelm antioxidant defenses instead of stimulating them. Neurological harm has been reported: Haggiag and colleagues (2021) described ozone-induced encephalopathy as a distinct, probably underreported iatrogenic entity in the European Journal of Neurology, usually linked to improper administration. This is why route and dose discipline matter.
Absolute and relative contraindications that a competent provider screens for, drawn from Smith and colleagues (2017) and standard ozone-medicine guidance:
- G6PD deficiency (glucose-6-phosphate dehydrogenase deficiency): an absolute contraindication because these patients risk hemolytic anemia under oxidative stress. Any provider who skips G6PD testing is a red flag.
- Pregnancy
- Uncontrolled hyperthyroidism
- Active bleeding or bleeding disorders
- Recent heart attack or stroke
Against those risks sits a large safety record for systemic use. Viebahn-Hansler, Leon Fernandez, and Fahmy (2016) reviewed roughly 11,000 major-autohemotherapy treatments in 577 patients and more than 47,000 rectal insufflations in 716 patients across the clinical literature, and found only two adverse events. For the full risk breakdown see ozone therapy safety and ozone therapy contraindications.
How Much Does Ozone Therapy Cost?
Ozone therapy is almost never covered by insurance, so patients pay out of pocket. Prices range from about $75 per session for rectal insufflation to $1,500 for 10-Pass or EBOO. A typical major-autohemotherapy course of 10 to 20 sessions runs $2,000 to $6,000. These are 2026 US clinic ranges and vary by city and provider.
| Modality | Cost Per Session | Typical Course | Total Cost Estimate |
|---|---|---|---|
| MAH (Single Pass) | $200-$300 | 10-20 sessions | $2,000-$6,000 |
| 10-Pass / Multi-Pass | $750-$1,500 | 6-10 sessions | $4,500-$15,000 |
| EBOO | $900-$1,500 | 4-8 sessions | $3,600-$12,000 |
| Rectal Insufflation | $75-$150 | 10-30 sessions | $750-$4,500 |
| Prolozone Injection | $150-$400 | 3-6 injections | $450-$2,400 |
Package discounts of 10 to 20 percent are common for multi-session bundles. A home-use medical-grade ozone generator runs $1,500 to $4,000 upfront, and only rectal and ear insufflation are considered safe for home use with training. Blood-based methods must be done in a clinic. For deeper pricing, see ozone therapy cost and the higher-dose 10-Pass ozone therapy cost.
How Do You Find a Qualified Ozone Therapy Provider?
Look for a licensed physician or naturopathic doctor with ozone-specific training who tests for G6PD deficiency before treatment and can explain their concentration and dosing protocol. The absence of standardized certification makes vetting harder than it should be, so the provider’s process and transparency are your best signals.
Credentials to prioritize: a licensed MD, DO, or ND with documented ozone training; membership in a recognized body such as the American Academy of Ozonotherapy or ISCO3; and G6PD testing as standard practice.
Questions worth asking: which modality they recommend and why, how many treatments they have administered, how they calibrate ozone concentration, and their protocol for adverse reactions.
Red flags: claims that ozone cures cancer, HIV, or any specific disease; no G6PD testing; direct intravenous ozone-gas injection; and pressure to prepay for large packages. Our guide to ozone therapy clinics and to how often to do ozone therapy covers vetting and scheduling in detail.
Ozone Therapy vs HBOT: What Is the Difference?
Ozone therapy and hyperbaric oxygen therapy (HBOT) are both oxygen-based but work in opposite ways. HBOT physically dissolves 100 percent oxygen into plasma under pressure. Ozone creates a brief oxidative stress that triggers the body’s own defenses. HBOT has 14 FDA-cleared indications and hundreds of RCTs; ozone has zero FDA approvals and a smaller evidence base.
In the only direct head-to-head human trial, Pasek and colleagues (2023) compared topical HBOT and ozone for venous leg ulcers in 114 patients. HBOT reduced ulcer area by 69.7 percent versus ozone’s 41.3 percent, but ozone provided significantly better pain relief.
“Topical hyperbaric oxygen therapy demonstrated superior overall outcomes, while ozone therapy provided greater pain relief, in the treatment of venous leg ulcers.”
Pasek et al., 2023, International Journal of Environmental Research and Public Health
The two are not mutually exclusive, and some clinics combine them for wounds and infections. For a fuller comparison including IV NAD+, see our HBOT vs ozone therapy vs IV NAD+ breakdown and the direct ozone therapy vs hyperbaric oxygen comparison. If oxygen delivery is your main goal, our oxygen therapy safety guide covers how the pressurized approach is used and monitored.
Is ozone therapy safe?
When a trained practitioner follows concentration protocols, systemic ozone therapy has a strong safety record. Viebahn-Hansler and colleagues (2016) reviewed roughly 11,000 major-autohemotherapy treatments and over 47,000 rectal insufflations with only two adverse events. The main risks come from improper administration, especially direct intravenous injection of ozone gas, which can cause air embolism, and inhalation. Screening for G6PD deficiency before treatment is essential. Choose a qualified provider and these risks are low.
Does ozone therapy really work?
For specific conditions, yes. The strongest human evidence supports intradiscal ozone for herniated-disc pain (Chang, 2024 meta-analysis) and intra-articular ozone for knee osteoarthritis (Sconza, 2020, 11 RCTs). Wound-healing data is positive but not clearly superior to standard care (Fitzpatrick, 2018). For many other conditions marketed with ozone, including cancer, HIV, and chronic Lyme, evidence is limited to laboratory studies or case reports. The mechanisms are real, but not every claim is supported by trials.
Is ozone therapy FDA-approved?
No. Ozone therapy has zero FDA approvals. Under 21 CFR 801.415 the FDA classifies ozone as a toxic gas with no proven medical use at safe concentrations, which means ozone generators cannot be marketed as medical devices. Medical practice, however, is regulated by states, and many allow licensed physicians to administer ozone under their license. It is legal and widely practiced across much of Europe, Cuba, and Mexico. HBOT, by contrast, has 14 FDA-cleared indications, a different and stronger regulatory status.
How much does ozone therapy cost?
Costs range from about $75 per session for rectal insufflation to $1,500 per session for 10-Pass or EBOO. A typical major-autohemotherapy course of 10 to 20 sessions runs $2,000 to $6,000 in 2026. Insurance almost never covers ozone therapy. Many clinics offer 10 to 20 percent package discounts for bundles. A home ozone generator for rectal insufflation costs $1,500 to $4,000 upfront, and only insufflation methods are safe for home use with training.
What is the difference between ozone therapy and oxygen therapy?
Oxygen therapy delivers O2 to raise tissue oxygen directly, as with supplemental oxygen, HBOT, or EWOT. Ozone therapy delivers O3 as a signaling molecule that triggers the body’s own repair and antioxidant systems through a brief oxidative stress. Oxygen therapy saturates tissue with oxygen; ozone therapy provokes an adaptive response. The mechanisms differ, and some clinics combine them for wounds and infections where both oxygen delivery and immune modulation help.
Sources
- Chang MC, Choo YJ, Denis I, Mares C, Majdalani C, Yang S. “Effectiveness of intradiscal ozone injections for treating pain following herniated lumbar disc: A systematic review and meta-analysis.” Journal of Back and Musculoskeletal Rehabilitation, 2024;37(5):1131-1139. doi:10.3233/BMR-240024
- Magalhaes FN, Dotta L, Sasse A, Teixeira MJ, Fonoff ET. “Ozone therapy as a treatment for low back pain secondary to herniated disc: a systematic review and meta-analysis of randomized controlled trials.” Pain Physician, 2012;15(2):E115-129. PMID 22430658
- Andreula CF, Simonetti L, De Santis F, Agati R, Ricci R, Leonardi M. “Minimally invasive oxygen-ozone therapy for lumbar disk herniation.” American Journal of Neuroradiology, 2003;24(5):996-1000. PMID 12748111
- Sconza C, et al. “Oxygen-Ozone Therapy for the Treatment of Knee Osteoarthritis: A Systematic Review of Randomized Controlled Trials.” Arthroscopy, 2020;36(1):277-286. doi:10.1016/j.arthro.2019.05.043
- Jeyaraman M, Jeyaraman N, Ramasubramanian S, Balaji S, Nallakumarasamy A, Patro BP, Migliorini F. “Ozone therapy in musculoskeletal medicine: a comprehensive review.” European Journal of Medical Research, 2024;29(1):421. doi:10.1186/s40001-024-01976-4
- Fitzpatrick E, Holland OJ, Vanderlelie JJ. “Ozone therapy for the treatment of chronic wounds: A systematic review.” International Wound Journal, 2018;15(4):633-644. doi:10.1111/iwj.12907
- Wainstein J, Feldbrin Z, Boaz M, Harman-Boehm I. “Efficacy of ozone-oxygen therapy for the treatment of diabetic foot ulcers.” Diabetes Technology & Therapeutics, 2011;13(12):1255-1260. doi:10.1089/dia.2011.0018
- Pasek J, Szajkowski S, Travagli V, Cieslar G. “Topical Hyperbaric Oxygen Therapy Versus Local Ozone Therapy in Healing of Venous Leg Ulcers.” International Journal of Environmental Research and Public Health, 2023;20(3):1967. doi:10.3390/ijerph20031967
- Romary DJ, et al. “Liquid ozone therapies for the treatment of epithelial wounds: A systematic review and meta-analysis.” International Wound Journal, 2023. doi:10.1111/iwj.13941
- Hu Y, et al. “Effects of ozone therapy as an adjuvant in the treatment of periodontitis: a systematic review and meta-analysis.” BMC Oral Health, 2025. doi:10.1186/s12903-025-05639-6
- Santos GM, Pacheco RL, Bussadori SK, et al. “Effectiveness and Safety of Ozone Therapy in Dental Caries Treatment: Systematic Review and Meta-analysis.” Journal of Evidence-Based Dental Practice, 2020. PMID 33303100
- Brazzelli M, McKenzie L, Fielding S, et al. “Systematic review of the effectiveness and cost-effectiveness of HealOzone for the treatment of occlusal pit/fissure caries and root caries.” Health Technology Assessment, 2006;10(16). PMID 16707073
- Sucuoglu H, Soydas N. “Efficacy of ozone therapy as an add-on treatment in fibromyalgia: A randomized double-blind placebo-controlled study.” Journal of Back and Musculoskeletal Rehabilitation, 2023;36(2):357-366. doi:10.3233/BMR-210368
- Hidalgo-Tallon J, Menendez-Cepero S, Vilchez JS, Rodriguez-Lopez CM, Calandre EP. “Ozone therapy as add-on treatment in fibromyalgia management by rectal insufflation: an open-label pilot study.” Journal of Alternative and Complementary Medicine, 2013;19(3):238-242. PMID 23046293
- Clavo B, Santana-Rodriguez N, Llontop P, et al. “Ozone Therapy as Adjuvant for Cancer Treatment: Is Further Research Warranted?” Evidence-Based Complementary and Alternative Medicine, 2018;2018:7931849. doi:10.1155/2018/7931849
- Clavo B, Rodriguez-Esparragon F, Rodriguez-Abreu D, et al. “Modulation of Oxidative Stress by Ozone Therapy in the Prevention and Treatment of Chemotherapy-Induced Toxicity: Review and Prospects.” Antioxidants, 2019;8(12):588. doi:10.3390/antiox8120588
- Carpendale MT, Freeberg JK. “Ozone inactivates HIV at noncytotoxic concentrations.” Antiviral Research, 1991;16(3):281-292. doi:10.1016/0166-3542(91)90007-E
- Sagai M, Bocci V. “Mechanisms of Action Involved in Ozone Therapy: Is healing induced via a mild oxidative stress?” Medical Gas Research, 2011;1:29. doi:10.1186/2045-9912-1-29
- Bocci V, Zanardi I, Travagli V. “Ozone acting on human blood yields a hormetic dose-response relationship.” Journal of Translational Medicine, 2011;9:66. doi:10.1186/1479-5876-9-66
- Leon OS, Menendez S, Merino N, et al. “Ozone oxidative preconditioning: a protection against cellular damage by free radicals.” Mediators of Inflammation, 1998;7(4):289-294. doi:10.1080/09629359890983
- Smith NL, Wilson AL, Gandhi J, Vatsia S, Khan SA. “Ozone therapy: an overview of pharmacodynamics, current research, and clinical utility.” Medical Gas Research, 2017;7(3):212-219. doi:10.4103/2045-9912.215752
- Elvis AM, Ekta JS. “Ozone therapy: A clinical review.” Journal of Natural Science, Biology and Medicine, 2011;2(1):66-70. doi:10.4103/0976-9668.82319
- Scassellati C, Galoforo AC, Bonvicini C, Esposito C, Ricevuti G. “Ozone: a natural bioactive molecule with antioxidant property as potential new strategy in aging and in neurodegenerative disorders.” Ageing Research Reviews, 2020;63:101138. doi:10.1016/j.arr.2020.101138
- Napiorkowska-Baran K, Slawatycki J, Klemenska P, et al. “Ozone as an Immunomodulator: New Therapeutic Possibilities in the Treatment of Immunodeficiencies. A Narrative Review.” Current Issues in Molecular Biology, 2025;47(12):1016. doi:10.3390/cimb47121016
- Viebahn-Hansler R, Leon Fernandez OS, Fahmy Z. “Ozone in Medicine: Clinical Evaluation and Evidence Classification of the Systemic Ozone Applications, Major Autohemotherapy and Rectal Insufflation, According to the Requirements for Evidence-Based Medicine.” Ozone: Science & Engineering, 2016;38(5):322-345. doi:10.1080/01919512.2016.1191992
- Viebahn-Hansler R, Leon Fernandez OS. “Ozone in Medicine. The Low-Dose Ozone Concept and Its Basic Biochemical Mechanisms of Action in Chronic Inflammatory Diseases.” International Journal of Molecular Sciences, 2021;22(15):7890. doi:10.3390/ijms22157890
- Haggiag S, Prosperini L, Stasolla A, Gerace C, Tortorella C, Gasperini C. “Ozone-induced encephalopathy: A novel iatrogenic entity.” European Journal of Neurology, 2021;28(8):2471-2478. doi:10.1111/ene.14793
- Serra MEG, Baeza-Noci J, Abdala CVM, Luvisotto MM, Bertol CD, Anzolin AP. “Clinical effectiveness of medical ozone therapy in COVID-19: the evidence and gaps map.” Medical Gas Research, 2023;13(4):172-180. doi:10.4103/2045-9912.372819
- Systematic review and meta-analysis. “Effect of ozone therapy on oxidative stress indices in chronic inflammatory diseases: a systematic review and meta-analysis of randomized clinical trials (12 RCTs, 846 participants).” Advances in Redox Research, 2025. ScienceDirect
- U.S. Food and Drug Administration. “21 CFR 801.415: Maximum acceptable level of ozone.” Code of Federal Regulations. eCFR
Medical Disclaimer
The content on BaricBoost.com is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
Author
Seph Fontane Pennock is the founder of BaricBoost.com and Regenerated.com, a clinic directory for regenerative medicine serving 10,000+ providers across the United States. He previously built and sold PositivePsychology.com, which grew to 19 million users and became the largest evidence-based positive psychology resource on the web. Seph brings direct experience as an HBOT patient, having completed protocols at clinics across three continents while navigating mold illness, systemic inflammation, and autoimmune conditions. His treatment journey includes hyperbaric oxygen therapy, peptide protocols, NAD+ therapy, and consultations with specialists from Dubai to Cape Town to Mexico. This combination of entrepreneurial track record and lived patient experience shapes everything published on BaricBoost.com. Every article is grounded in peer-reviewed research, informed by real clinical encounters, and written for patients making high-stakes treatment decisions. Seph's focus is on bringing transparency, scientific rigor, and practical guidance to the hyperbaric oxygen therapy space.
